Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance have?
Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance has 104 citations in the OpenAlex counts ScholarIQ stores.
When was Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance published?
Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance has 2023 year in the ScholarIQ index.
What is the open-access status of Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance?
Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance has hybrid oa status in the ScholarIQ index.
What is the DOI of Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance?
The DOI for Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance is on the source record.
What is the PMID of Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance?
The PMID for Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance is on the source record.
What is the OpenAlex record for Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance?
The OpenAlex for Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance is on the source record.